Genitourinary Cancer News

American Society for Radiation Oncology has announced Howard Sandler, MD, FASTRO, as its new president-elect, along with several new officers elected to its board of directors, according to a press release.

The FDA granted fast track designation to abelacimab for treatment of cancer-associated thrombosis, according to a press release from the agent’s manufacturer.

The development of targeted cancer therapies has led to improved clinical outcomes for many patients. However, monotherapies against a single target can result in treatment resistance.

When Aparna Surapaneni, MD, began working in Memorial Hermann Health System’s radiation oncology department 6 years ago, she noticed a pull-up bar right outside her office.

Various sociodemographic and socioeconomic factors, including race/ethnicity and insurance status, correlated with receipt of immunotherapy among patients with melanoma and kidney and lung cancers.

The ideal strategy to treat cancer with cell therapy can vary greatly depending on tumor type.

Active systemic cancer treatment did not appear associated with increased mortality among patients with cancer and COVID-19, according to study results published in JAMA Network Open.

CHICAGO — Cabozantinib plus atezolizumab showed encouraging clinical activity in patients with inoperable locally advanced or metastatic urothelial carcinoma, according to data from the COSMIC-021 study.

CHICAGO — Better health-related quality of life was linked to longer survival in patients with intermediate- or poor-risk renal cell carcinoma, according to an analysis of the CheckMate 214 trial.

CHICAGO — Deeper response to treatment was associated with improved progression-free and overall survival in patients with advanced renal cell carcinoma, according to data from the CheckMate 9ER trial.